These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 32553244
41. Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia. Ueda Y, Miwa T, Gullipalli D, Sato S, Ito D, Kim H, Palmer M, Song WC. J Am Soc Nephrol; 2018 Jul; 29(7):1928-1937. PubMed ID: 29858280 [Abstract] [Full Text] [Related]
48. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice. Zhang Y, Keenan A, Dai DF, May KS, Anderson EE, Lindorfer MA, Henrich JB, Pitcher GR, Taylor RP, Smith RJ. JCI Insight; 2020 May 07; 5(9):. PubMed ID: 32376801 [Abstract] [Full Text] [Related]
49. Propensity score-matched analysis of long-term outcomes for living kidney donation in alternative complement pathway diseases: a pilot study. Caliskan Y, Safak S, Oto OA, Velioglu A, Yelken B, Mirioglu S, Dirim AB, Yildiz A, Guller N, Yazici H, Ersoy A, Turkmen A, Lentine KL. J Nephrol; 2023 May 07; 36(4):979-986. PubMed ID: 36808609 [Abstract] [Full Text] [Related]
51. Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis. Aradottir SS, Kristoffersson AC, Roumenina LT, Bjerre A, Kashioulis P, Palsson R, Karpman D. Front Immunol; 2021 May 07; 12():690821. PubMed ID: 34177949 [Abstract] [Full Text] [Related]
52. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies. Loeven MA, Maciej-Hulme ML, Yanginlar C, Hubers MC, Kellenbach E, de Graaf M, van Kuppevelt TH, Wetzels J, Rabelink TJ, Smith RJH, van der Vlag J. Front Immunol; 2021 May 07; 12():676662. PubMed ID: 34489931 [Abstract] [Full Text] [Related]
53. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome. Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D. Am J Kidney Dis; 2018 Feb 07; 71(2):287-290. PubMed ID: 29248304 [Abstract] [Full Text] [Related]
55. Genetics of atypical hemolytic uremic syndrome (aHUS). Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A. Semin Thromb Hemost; 2014 Jun 07; 40(4):422-30. PubMed ID: 24799305 [Abstract] [Full Text] [Related]
56. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome. Siomou E, Gkoutsias A, Serbis A, Kollios K, Chaliasos N, Frémeaux-Bacchi V. Pediatr Nephrol; 2016 Mar 07; 31(3):513-7. PubMed ID: 26572892 [Abstract] [Full Text] [Related]
58. Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome. Gómez Delgado I, Corvillo F, Nozal P, Arjona E, Madrid Á, Melgosa M, Bravo J, Szilágyi Á, Csuka D, Veszeli N, Prohászka Z, Sánchez-Corral P. Front Immunol; 2021 Mar 07; 12():641656. PubMed ID: 33777036 [Abstract] [Full Text] [Related]
59. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement. Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH. Am J Reprod Immunol; 2015 Oct 07; 74(4):345-56. PubMed ID: 26011580 [Abstract] [Full Text] [Related]